Common TitleRESOLVE
Official Title A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)
Phase Phase IIB
ClinicalTrials.gov NCT02745535
Treatments
Sofosbuvir-Velpatasvir-Voxilaprevir
Sofosbuvir-Velpatasvir-Voxilaprevir
Tradename:VoseviOther Names:SOF-VEL-VOXClass:FDA-ApprovedFunding
IndustryGilead Sciences
Non-IndustryIntramural Research Pro- gram of the NIH, Clinical Center
